Brought to you by 
Cardiac Pathways raises $32mm in Series B financing
07 Sep 1999
Executive Summary
Publicly traded tachyarrhythmia systems developer Cardiac Pathways raised $32mm through a private placement of 32,000 shares of Series B preferred stock, priced at $1,000 each. Each share of the Series B stock is convertible into 200 of CP's post-split common shares. The company will use proceeds for expansion of marketing and R&D programs.
Deal Industry
-
Medical Devices
- Diagnostic Equipment & Supplies
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cardiac Pathways raises $32mm in Series B financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice